| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Interest Income | 11,614,868 | 8.258% | 10,728,849 | 10,358,562 | 9,429,391 | 8,755,280 |
| Interest Expense | (7,378,650) | 3.403% | (7,135,847) | (6,804,515) | (5,988,687) | (5,496,250) |
| Net Interest Income | 4,236,218 | 17.902% | 3,593,002 | 3,554,047 | 3,440,704 | 3,259,030 |
| Other Operating Income | 1,565,970 | -6.070% | 1,667,172 | 1,836,686 | 1,427,309 | 1,829,911 |
| Total Operating Income | 5,802,188 | 10.304% | 5,260,174 | 5,390,733 | 4,868,013 | 5,088,941 |
| Net Insurance Claims Incurred & Movement in Policyholders' Liabilities | 0 | -- | 0 | 0 | 0 | 0 |
| Net Operating Income | 5,802,188 | 10.304% | 5,260,174 | 5,390,733 | 4,868,013 | 5,088,941 |
| Operating Expenses | (2,348,411) | 7.395% | (2,186,703) | (2,070,493) | (1,824,285) | (1,836,783) |
| Impairment Losses on Loans & Advances | (959,069) | -21.983% | (1,229,305) | (1,487,085) | (992,493) | (1,008,870) |
| Other Impairment Losses | (472,961) | 5382.335% | (8,627) | (165,842) | (460,439) | (656,611) |
| Operating Profit / (Loss) | 2,021,747 | 10.145% | 1,835,539 | 1,667,313 | 1,590,796 | 1,586,677 |
| Change in FV & Impairment on Inv. Prop. | 0 | -- | 0 | 0 | 0 | 0 |
| Change in FV & Impairment on Others | 0 | -- | 0 | 0 | 0 | 0 |
| Profit / (Loss) on Disposal | 0 | -- | 0 | 0 | 0 | 0 |
| Other Non-operating Items | 0 | -- | 0 | 0 | 0 | 0 |
| Share of Results of Asso. & JCEs | 12,143 | -41.575% | 20,784 | 24,505 | 21,543 | 20,878 |
| Profit / (Loss) before Taxation | 2,033,890 | 9.566% | 1,856,323 | 1,691,818 | 1,612,339 | 1,607,555 |
| Taxation | (33,339) | 59.121% | (20,952) | (12,460) | (41,474) | (125,107) |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- |
| Non-controlling Interests | 2,360 | -22.009% | 3,026 | 6,270 | (4,153) | 1,182 |
| Others | -- | -- | -- | -- | -- | -- |
| Profit / (Loss) Attributable to Shareholders | 2,002,911 | 8.949% | 1,838,397 | 1,685,628 | 1,566,712 | 1,483,630 |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Depreciation & Amortisation | 320,183 | -1.281% | 324,338 | 320,427 | 278,342 | 256,415 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| EPS (cts) | 34.000 | 9.677% | 31.000 | 29.000 | 27.000 | 28.000 |
| DPS (cts) | 10.000 | -- | 10.000 | 10.000 | 10.000 | 11.000 |
| Dividend Payout Ratio (%) | 29.412% | -- | 32.258% | 34.483% | 37.037% | 39.286% |
| Cash flow per share ($) | 1.415 | -- | 4.279 | 0.447 | 0.020 | 3.199 |
| NBV per share ($) | 4.247 | -- | 3.997 | 3.791 | 3.599 | 3.449 |
| Remarks: | Real time quote last updated: 06/01/2026 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 2,002,911 |
| %Change | 8.949% |
| EPS / (LPS) | RMB 0.340 |
| NBV Per Share (¥) | RMB 4.247 |